The Board of Directors approved 2021 consolidated financial statements.
· Issued by Excelsior Medical Co., Ltd.
Close
Today's Information
Provided by: EXCELSIOR MEDICAL CO.,LTD
SEQ_NO
5
Date of announcement
2022/03/11
Time of announcement
18:32:22
Subject
The Board of Directors approved 2021 consolidated
financial statements.
Date of events
2022/03/11
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/03/11
2.Date of approval by the audit committee:2022/03/11
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):6,573,152
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,372,619
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):595,026
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):873,736
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):722,289
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):607,149
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):4.30
11.Total assets end of the period (thousand NTD):15,105,000
12.Total liabilities end of the period
(thousand NTD):5,359,288
13.Equity attributable to owners of parent end of the
period (thousand NTD):7,738,389
14.Any other matters that need to be specified:None.
